Sharps Technology Signs LOI with Roncadelle Operations Intended to Open Worldwide Sales and Distribution Opportunities for Safe Drug Delivery Systems
18 janv. 2024 09h00 HE
|
Sharps Technology Inc
NEW YORK, Jan. 18, 2024 (GLOBE NEWSWIRE) -- Sharps Technology, Inc., (NASDAQ: “STSS” and “STSSW”), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class...
Sharps Technology Announces Closing of $5.6 Million Registered Direct and Private Placement
29 sept. 2023 09h54 HE
|
Sharps Technology Inc
Sharps Technology Announces Closing of $5.6 Million Registered Direct and Private Placement
Sharps Technology Issues Letter to Shareholders Covering the Announced Asset Purchase Agreement to Acquire InjectEZ Prefillable Syringe Manufacturing Facility and the Associated $400 Million 10-Year Purchase Agreement with Nephron Pharmaceuticals
28 sept. 2023 10h52 HE
|
Sharps Technology Inc
Sharps Technology Issues Letter to Shareholders Covering the Announced Asset Purchase Agreement to Acquire InjectEZ Prefillable Syringe Manufacturing Facil
UPDATE - Sharps Technology Announces $5.6 Million Registered Direct and Private Placement Priced at the Market Under Nasdaq Rules
27 sept. 2023 12h03 HE
|
Sharps Technology Inc
NEW YORK, Sept. 27, 2023 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the “Company”) (NASDAQ: “STSS” and “STSSW”), an innovative medical device and pharmaceutical packaging company offering...
Sharps Technology Announces $5.6 Million Registered Direct and Private Placement Priced at the Market Under Nasdaq Rules
27 sept. 2023 09h14 HE
|
Sharps Technology Inc
Sharps Technology Announces $5.6 Million Registered Direct and Private Placement Priced at the Market Under Nasdaq Rules
Sharps Technology Signs Asset Purchase Agreement to Acquire InjectEZ Specialty Copolymer Syringe Manufacturing Facility and a 10-Year Purchase Agreement for Over $400 Million from Nephron Pharmaceuticals
26 sept. 2023 08h30 HE
|
Sharps Technology Inc
Sharps Technology Signs Asset Purchase Agreement to Acquire InjectEZ for $50M and 10-Year Purchase Agreement for Over $400 Million from Nephron
Sharps Technology Appoints Industry Sales and Manufacturing Leader Ben Scheu as Senior Director of Sales
12 juil. 2023 08h33 HE
|
Sharps Technology Inc
Key appointment with demonstrated experience in leading sales and marketing operations to oversee commercial initiatives as the Company launches its specialty smart safety syringe products to the...
Sharps Technology Provides Update on Commercialization Activities and is Highlighted in Med Tech Outlook Feature Article
06 juil. 2023 07h50 HE
|
Sharps Technology Inc
Company advances commercialization of Securegard smart safety syringe product linethrough qualification programs with a major medical device company Production of prefilled syringe products will...
Sharps Technology Issues Update Letter to Shareholders from CEO Robert Hayes
04 avr. 2023 08h00 HE
|
Sharps Technology Inc
Commercial revenue from specialty safety syringe systems is advancing Company to launch its vial draw syringe systems in Q2 2023Launch of high-value, next-generation polymer-based products expected in...
Sharps Technology Appoints Justin Page as Vice President of Technical Operations
09 févr. 2023 09h21 HE
|
Sharps Technology Inc
NEW YORK, Feb. 09, 2023 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the “Company”, "Sharps") (NASDAQ: “STSS” and “STSSW”), an innovative medical device and drug delivery Company offering patented,...